Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study

INTRODUCTION: Programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assessment is mandatory for the single agent pembrolizumab treatment of patients with advanced non-small cell lung cancer (NSCLC). PD-L1 testing has been validated and is currently certified only on formalin-fixed paraffin-em...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Med Oncol
Autors principals: Ricci, Costantino, Capizzi, Elisa, Giunchi, Francesca, Casolari, Laura, Gelsomino, Francesco, Rihawi, Karim, Natali, Filippo, Livi, Vanina, Trisolini, Rocco, Fiorentino, Michelangelo, Ardizzoni, Andrea
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7711224/
https://ncbi.nlm.nih.gov/pubmed/33299472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920954802
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars